Skip to main content

Table 2 Concentrations of total and HMWA in patients with and without the metabolic syndrome

From: Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance

  Total adiponectin
(μg/ml)
P HMWA
(μg/ml)
P
ATP criteria     
All (n = 269)     
Metabolic syndrome (n = 77) 7.26 [3.57] 0.006 4.10 [3.07] 0.007
No metabolic syndrome (n = 192) 8.91 [4.84]   5.05 [4.03]  
Men (n = 101)     
Metabolic syndrome (n = 30) 6.44 [2.94] 0.183 3.25 [2.13] 0.245
No metabolic syndrome (n = 71) 7.32 [2.65]   3.50 [3.00]  
Women (n = 168)     
Metabolic syndrome (n = 47) 8.68 [4.58] 0.024 4.60 [5.00] 0.037
No metabolic syndrome (n = 121) 10.06 [4.91]   5.80 [4.20]  
IDF criteria     
All (n = 269)     
Metabolic syndrome (n = 102) 7.27 [3.39] < 0.001 3.95 [2.48] < 0.001
No metabolic syndrome (n = 167) 9.11 [4.98]   5.40 [4.40]  
Men (n = 101)     
Metabolic syndrome (n = 45) 6.68 [2.79] 0.123 3.20 [1.80] 0.114
No metabolic syndrome (n = 56) 7.52 [2.93]   3.55 [3.48]  
Women (n = 168)     
Metabolic syndrome (n = 57) 8.68 [4.33] 0.002 4.60 [4.55] 0.007
No metabolic syndrome (n = 111) 10.48 [4.71]   6.20 [4.40]  
  1. Values are medians [IQR]. Number of subjects in each group is indicated in parentheses.